SCHEMBL3763587

SCHEMBL3763587

CCCCCCCCCCCCCC=CC(O)C(N)COP(O)(O)=S

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 3/20 0.76
▸ S1PR4 O95977 2/20 0.76
▸ S1PR3 Q99500 2/20 0.76
▸ S1PR5 Q9H228 2/20 0.76
▸ ALDH1A1 P00352 2/20 0.76
▸ S1PR2 O95136 1/20 0.76
▸ TSPO P30536 1/20 0.76
▸ TMEM97 Q5BJF2 1/20 0.76
▸ SIGMAR1 Q99720 1/20 0.76
▸ MEN1 O00255 4/20 0.60
▸ KMT2A Q03164 4/20 0.60
▸ MAPT P10636 3/20 0.60
▸ CETP P11597 3/20 0.60
▸ BLM P54132 3/20 0.60
▸ GMNN O75496 2/20 0.60
▸ LMNA P02545 2/20 0.60
▸ GLA P06280 2/20 0.60
▸ POLB P06746 2/20 0.60
▸ THRB P10828 2/20 0.60
▸ MAPK1 P28482 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2561998 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL8736952 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL6055753 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL12766764 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL3885 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL17482409 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL3517452 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL22910837 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL20798182 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1
SCHEMBL29380297 0.86 S1PR1 (1.00) S1PR1S1PR4S1PR3S1PR5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190183910-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS OKTAY, KUTLUK (US) 2019-06-20 — — US claimed
WO-2017223152-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS NEW YORK MEDICAL COLLEGE (US) 2017-12-28 — — WO claimed
US-5877167-A Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives OTSUKA AMERICA PHARMACEUTICAL, INC. (US) 1999-03-02 — — US claimed
EP-0671917-A4 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES. BIOMEMBRANE INST (US) 1997-06-18 — — EP claimed
EP-0671917-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES ONCOMEMBRANE, INC. (US) 1995-09-20 — — EP claimed
US-5260288-A Administering an inflammation inhibitory amount THE BIOMEMBRANE INSTITUTE (US) 1993-11-09 — — US claimed
WO-1993019760-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES THE BIOMEMBRANE INSTITUTE (US) 1993-10-14 — — WO claimed
US-20230152317-A1 DIAGNOSIS AND TREATMENT OF COVID-19 LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2023-05-18 — — US disclosed
WO-2021207858-A1 DIAGNOSIS AND TREATMENT OF COVID-19 LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2021-10-21 — — WO disclosed
US-20190183910-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS OKTAY, KUTLUK (US) 2019-06-20 — — US disclosed
WO-2017223152-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS NEW YORK MEDICAL COLLEGE (US) 2017-12-28 — — WO disclosed
US-7850984-B2 Protection of the female reproductive system from natural and artificial insults THE GENERAL HOSPITAL CORPORATION (US) 2010-12-14 — — US disclosed
US-20070157331-A1 Protection of female reproductive system from natural and artifical insults MASSACHUSETTS GENERAL HOSPITAL, PARTNERS HEALTHCARE RESEARCH VENTURES & LICENSING (US) 2007-07-05 — — US disclosed
EP-1257245-A2 PROTECTION OF THE FEMALE REPRODUCTIVE SYSTEM FROM NATURAL AND ARTIFICIAL INSULTS Sloan-Kettering Institute For Cancer Research (US) 2002-11-20 — — EP disclosed
WO-2001060318-A2 PROTECTION OF THE FEMALE REPRODUCTIVE SYSTEM FROM NATURAL AND ARTIFICIAL INSULTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2001-08-23 — — WO disclosed
US-5952152-A POLYMERIZABLE MIXTURE COMPRISING AT LEAST ONE ETHYLENICALLY UNSATURATED COMPOUND AND AN ANIONIC BORON COMPOUND ACTIVATOR CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-09-14 — — US disclosed
US-5877167-A Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives OTSUKA AMERICA PHARMACEUTICAL, INC. (US) 1999-03-02 — — US disclosed
US-5663404-A ANTITUMOR AGENTS; ANTIINFLAMMATORY AGENTS ONCOMEMBRANE (US) 1997-09-02 — — US disclosed
US-5391800-A Protecting hydroxyl groups of sphingosine, deprotecting C1, phosphorylating, deprotecting C3; free of L-threo isomer THE BIOMEMBRANE INSTITUTE (US) 1995-02-21 — — US disclosed
US-5260288-A Administering an inflammation inhibitory amount THE BIOMEMBRANE INSTITUTE (US) 1993-11-09 — — US disclosed
Send feedback